BC

Barnabas Cangan Alphonsal

Active Director Director DIN 10685953
DIN 10685953 First appointment Jun 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Barnabas Cangan Alphonsal

Data last updated:

Barnabas Cangan Alphonsal is a Director at Insulingate Private Limited (since 2024). Insulingate Private Limited reported revenue of ₹37,976 (FY 2025).

DIN 10685953
Primary Designation Director
First Appointment 27 Jun 2024
Oldest Company Age 2 yrs
Largest company Insulingate Private Limited · ₹37,976 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Insulingate Private Limited U62013TN2024PTC171455
Director27 Jun 20242024₹37,976 (FY 2025)Active

Board colleagues of Barnabas Cangan Alphonsal

NameDINCompanyDesignation
John Prix Mascarenhas10685952Insulingate Private LimitedDirector

Directorship timeline

Open interactive timeline →
Insulingate Private Limited
Premium access

Shareholding and investment profile for Barnabas Cangan Alphonsal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Barnabas Cangan Alphonsal

Barnabas Cangan Alphonsal currently holds 1 directorship: Insulingate Private Limited (Director, since 27 Jun 2024, revenue ₹37,976 (FY 2025)).

Barnabas Cangan Alphonsal was first appointed on 27 Jun 2024 as Director at Insulingate Private Limited.

The current boards of Barnabas Cangan Alphonsal's companies include John Prix Mascarenhas (Insulingate Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available